Codexis (CDXS) Non-Current Assets (2010 - 2026)
Codexis (CDXS) recorded quarterly Non-Current Assets of $42.2 million in Q1 2026, down 3.23% quarter-over-quarter from $43.6 million in Q4 2025, and down 4.06% on a YoY basis from $44.0 million in Q1 2025.
Codexis (CDXS) Non-Current Assets (2010 - 2026) Analysis & Trends
Codexis' Non-Current Assets history runs 17 years deep, the most recent figure standing at $42.2 million for Q1 2026.
- In Q1 2026, Non-Current Assets fell 4.06% year-over-year to $42.2 million; the TTM figure through Mar 2026 stood at $42.2 million (down 4.06% YoY), while the FY2025 annual figure was $43.6 million, up 1.11% from the prior year.
- Non-Current Assets was $42.2 million for Q1 2026 at Codexis, down from $43.6 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $66.4 million in Q1 2022 to a low of $24.3 million in Q3 2024.
- Historically, Non-Current Assets has averaged $45.3 million across 5 years, with a median of $43.1 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets soared 112.45% in 2022, then sank 56.92% in 2024.
- A 5-year view of Non-Current Assets shows it stood at $61.9 million in 2022, then plunged by 53.74% to $28.6 million in 2023, then jumped by 50.57% to $43.1 million in 2024, then rose by 1.11% to $43.6 million in 2025, then retreated by 3.23% to $42.2 million in 2026.
- The last three Non-Current Assets figures came in at $42.2 million (Q1 2026), $43.6 million (Q4 2025), and $40.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 62,953.78 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 39.71 Mn |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 42.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.17 Mn |
| Dec 31, 2025 | 43.58 Mn |
| Sep 30, 2025 | 40.62 Mn |
| Jun 30, 2025 | 42.37 Mn |
| Mar 31, 2025 | 43.95 Mn |
| Dec 31, 2024 | 43.10 Mn |
| Sep 30, 2024 | 24.28 Mn |
| Jun 30, 2024 | 25.88 Mn |
| Mar 31, 2024 | 27.03 Mn |
| Dec 31, 2023 | 28.62 Mn |
| Sep 30, 2023 | 29.18 Mn |
| Jun 30, 2023 | 60.07 Mn |
| Mar 31, 2023 | 61.62 Mn |
| Dec 31, 2022 | 61.88 Mn |
| Sep 30, 2022 | 63.81 Mn |
| Jun 30, 2022 | 65.40 Mn |
| Mar 31, 2022 | 66.39 Mn |
| Dec 31, 2021 | 65.46 Mn |
| Sep 30, 2021 | 35.65 Mn |
| Jun 30, 2021 | 31.42 Mn |